Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance

Hannun, 1989, Functions of sphingolipids and sphingolipid breakdown products in cellular regulation, Science, 243, 500, 10.1126/science.2643164 Perry, 1998, The role of ceramide in cell signaling, Biochim Biophys Acta, 1436, 233, 10.1016/S0005-2760(98)00145-3 Hannun, 1994, The sphingomyelin cycle and the second messenger function of ceramide, J Biol Chem, 269, 3125, 10.1016/S0021-9258(17)41834-5 Bielawska, 1996, (1S,2R)-D-erythro-2-(N-myristoylamino)- 1-phenyl-1-propanol as an inhibitor of ceramidase, J Biol Chem, 271, 12646, 10.1074/jbc.271.21.12646 Abe, 1995, Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth, J Lipid Res, 36, 611, 10.1016/S0022-2275(20)39895-3 Wang, 1991, Inhibition of sphingolipid biosynthesis by fumonisins, J Biol Chem, 266, 14486, 10.1016/S0021-9258(18)98712-0 Merrill, 2001, Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins, Environ Health Perspect, 109(suppl 2), 283, 10.1289/ehp.01109s2283 Fishbein, 1993, Ceramide-mediated growth inhibition and CAPP are conserved in Saccharomyces cerevisiae, J Biol Chem, 268, 9255, 10.1016/S0021-9258(18)98343-2 Dobrowsky, 1992, Ceramide stimulates a cytosolic protein phosphatase, J Biol Chem, 267, 5048, 10.1016/S0021-9258(18)42727-5 Dobrowsky, 1993, Ceramide-activated protein phosphatase: partial purification and relationship to protein phosphatase 2A, Adv Lipid Res, 25, 91 Wolff, 1994, Role of ceramideactivated protein phosphatase in ceramide-mediated signal transduction, J Biol Chem, 269, 19605, 10.1016/S0021-9258(17)32212-3 Dobrowsky, 1993, Ceramide activates heterotrimeric protein phosphatase 2A, J Biol Chem, 268, 15523, 10.1016/S0021-9258(18)82288-8 Law, 1995, The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2-ceramide, J Biol Chem, 270, 12808, 10.1074/jbc.270.21.12808 Bourbon, 2000, Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex, J Biol Chem, 275, 35617, 10.1074/jbc.M007346200 Procky, 2000, Lipopolysaccharide induces jun N-terminal kinase activation in macrophages by a novel Cdc42/Rac-independent pathway involving sequential activation of protein kinase C zeta and phosphatidylcholinedependent phospholipase C, Blood, 96, 2592, 10.1182/blood.V96.7.2592 Conway, 2000, Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells, Cell Signal, 12, 737, 10.1016/S0898-6568(00)00119-4 Heinrich, 1999, Cathepsin D Targeted by acid-sphingomyelinase-derived ceramide, EMBO J, 18, 5252, 10.1093/emboj/18.19.5252 Heinrich, 2000, Ceramide as an activator lipid of cathepsin D, Adv Exp Med Biol, 477, 305, 10.1007/0-306-46826-3_33 Obeid, L. M. Linardic, C. M. Karolak, L. A. Hannun, Y. A. Programmed cell death induced by ceramide Science, 1993, 259, 1769, 1771 Smyth, 1996, prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of bcl-2, Biochem J, 316, 25, 10.1042/bj3160025 Mizushima, 1996, Ceramide induces apoptosis via CPP32 activation, FEBS Lett., 395, 267, 10.1016/0014-5793(96)01050-2 Zhang, 1996, Bcl-2 interrupts the ceramide-mediated pathway of cell death, Proc Natl Acad Sci USA, 93, 5325, 10.1073/pnas.93.11.5325 Wang, 1999, Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-kB/JNK kinase and cell survival, J Neurosci Res, 55, 293, 10.1002/(SICI)1097-4547(19990201)55:3<293::AID-JNR4>3.0.CO;2-9 Cesaro, 2001, Expression of protein kinase Cβ1 confers resistance to TNFα- and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells, Int J Cancer, 93, 179, 10.1002/ijc.1314 Dbaibo, 1998, p53-dependent ceramide response to genotoxic stress, J Clin Invest, 102, 329, 10.1172/JCI1180 Hannun, 1996, Functions of ceramide in coordinating cellular response to stress, Science, 274, 1855, 10.1126/science.274.5294.1855 Dbaibo, 1995, Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest, Proc Natl Acad Sci USA, 92, 1347, 10.1073/pnas.92.5.1347 Rani, 1995, Cell ceycle arrest induced by an inhibitor of glucosylceramide synthase, J Biol Chem, 270, 2859, 10.1074/jbc.270.6.2859 Lee, 2000, Regulation of cyclin-dependent kinase 2 activity by ceramide, Exp Cell Res, 261, 303, 10.1006/excr.2000.5028 Charles, 2000, Ceramide-coated ballon catheters limit neointimal hyperplasia after strech injury in carotid arteries, Circ Res, 87, 282, 10.1161/01.RES.87.4.282 Bourbon, N. A. Sandirasegarane, L. Kester, M. Ceramide-induced inhibition of Akt is mediated through PK Czeta: implications for growth arrest, J Biol Chem, Okazaki, 1989, Sphingomyelin turnoverinduced by vitamin D3 in HL-60 cells, J Biol Chem, 264, 19076, 10.1016/S0021-9258(19)47268-2 Dobrowsky, 1994, Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor, Science, 265, 1596, 10.1126/science.8079174 Venable, 1995, Role of ceramide in cellular senescence, J Biol Chem, 270, 30701, 10.1074/jbc.270.51.30701 Guillas, 2001, C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p, EMBO J, 20, 2655, 10.1093/emboj/20.11.2655 Ogretmen, 2001, Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells, J Biol Chem, 276, 24901, 10.1074/jbc.M100314200 Ogretmen, 2001, Molecular mechanisms of ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line, J Biol Chem, 276, 32506, 10.1074/jbc.M101350200 Chung, 2000, Sphingolipids signal heat stressinduced ubiquitin-dependent proteolysis, J Biol Chem, 275, 17229, 10.1074/jbc.C000229200 Dbaibo, 1997, Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway, J Exp Med, 185, 481, 10.1084/jem.185.3.481 Jarvis, 1994, Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway, Proc Natl Acad Sci USA, 91, 73, 10.1073/pnas.91.1.73 Cifone, 1994, Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase, J Exp Med, 180, 1547, 10.1084/jem.180.4.1547 Venable, 1995, Role of ceramide in cellular senescence, J Biol Chem, 270, 30701, 10.1074/jbc.270.51.30701 Jayadev, 1995, Role for ceramide in cell cycle arrest, J Biol Chem, 270, 2047, 10.1074/jbc.270.5.2047 Jarvis, 1994, Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells, J Biol Chem, 269, 31685, 10.1016/S0021-9258(18)31750-2 Bielawska, 1992, Ceramide-mediated biology: determination of structural and stereospecific requirements through the use of N-acyl-phenylaminoalcohol analogs, J Biol Chem, 267, 18493, 10.1016/S0021-9258(19)36989-3 Abe, 1995, Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth, J Lipid Res, 36, 611, 10.1016/S0022-2275(20)39895-3 Bielawska, 1996, (1S, 2R)-D-erythro-2-(N-Myristoylamino)- 1-phenyl-1-propanol (D-e-MAPP) as an inhibitor of ceramidase, J Biol Chem, 271, 12646, 10.1074/jbc.271.21.12646 Zhang, 1997, Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis, J Biol Chem, 272, 9609, 10.1074/jbc.272.15.9609 Jenkins, 1997, Involvement of yeast sphingolipids in the heat stress response of Saccharomyces cerevisiae, J Biol Chem, 272, 32566, 10.1074/jbc.272.51.32566 Wells, 1998, Heat-induced elevation of ceramide in Saccharomyces cerevisiae via de novo synthesis, J Biol Chem, 273, 7235, 10.1074/jbc.273.13.7235 Dawkins, 2001, Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I, Nature Gen, 27, 309, 10.1038/85879 Bose, 1995, Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals, Cell, 82, 405, 10.1016/0092-8674(95)90429-8 Kalén, 1992, Elevated ceramide levels in GH4C1 cells treated with retinoic acid, Biochim Biophys Acta Lipids Lipid Metab, 1125, 90, 10.1016/0005-2760(92)90160-W Plo, 1999, Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death, Neuroreport, 10, 2373, 10.1097/00001756-199908020-00028 Liao, 1999, Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase, J Biol Chem, 274, 17908, 10.1074/jbc.274.25.17908 Lehtonen, 1999, Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis, J Biol Chem, 274, 16901, 10.1074/jbc.274.24.16901 Xu, 1998, Involvement of de novo ceramide biosynthesis in tumor necrosis factor-cycloheximide-induced cerebral endothelial cell death, J Biol Chem, 273, 16521, 10.1074/jbc.273.26.16521 Santana, 1996, Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis, Cell, 86, 189, 10.1016/S0092-8674(00)80091-4 Lavie, 1997, Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells, J Biol Chem, 272, 1682, 10.1074/jbc.272.3.1682 Liu, 1999, Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells, J Biol Chem, 274, 1140, 10.1074/jbc.274.2.1140 Grullich, 2000, CD95 (Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis, J Biol Chem, 275, 8650, 10.1074/jbc.275.12.8650 Cremesti, 2001, Ceramide enables fax to ca and kill, J Biol Chem, 276, 23954, 10.1074/jbc.M101866200 Raisova, 2000, Resistance to CD95/Fas-induced and ceramide- mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release, FEBS Lett, 473, 27, 10.1016/S0014-5793(00)01491-5 Chalfant, 2001, FAS activation induces dephosphorylation of SR proteins: Dependence on the de novo generation of ceramide and activation of protein phosphatase 1, J Biol Chem, 276, 44848, 10.1074/jbc.M106291200 Merrill, 1992, Enzymes of ceramide biosynthesis, Methods Enzymol, 209, 427, 10.1016/0076-6879(92)09053-6 Hoekstra, 1999, Ceramide-mediated apoptosis of hepatocytes in vivo: a matter of the nucleus, J Hepatol, 31, 161, 10.1016/S0168-8278(99)80178-0 Chatterjee, 1999, Neutral sphingomyelinase: past, present and future, Chem Phys Lipids, 102, 79, 10.1016/S0009-3084(99)00077-8 Luberto, 2000, Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV-40-transformed human fibroblasts, J Biol Chem, 275, 14760, 10.1074/jbc.275.19.14760 El Bawab, 2000, Molecular cloning and characterization of a human mitochondrial ceramidase, J Biol Chem, 275, 21508, 10.1074/jbc.M002522200 El Bawab, 2001, Biochemical characterization of the reverse activity of rat brain ceramidase: A CoA-independent and fumonisin B1-insensitive ceramide synthase, J Biol Chem, 276, 16758, 10.1074/jbc.M009331200 Tepper, 2000, Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology, J Cell Biol, 150, 155, 10.1083/jcb.150.1.155 Birbes, 2001, Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis, FASEB J, 10.1096/fj.01-0539com Vielhaber, 2001, Mouse anti-ceramide antiserum: a specific tool for the detection of endogenous ceramide, Glycobiology, 11, 451, 10.1093/glycob/11.6.451 Veldman, 2001, A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling, Biochem J, 355, 859, 10.1042/bj3550859 Bezombes, 2001, Oxidative Stress- induced activation of Lyn recruits sphingomyelinase and is requisite for its stimulation by Ara-C1, FASEB J, 15, 1583, 10.1096/fj.00-0787fje Sawada, 2000, Influence of bax or bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells, Oncogene, 19, 3508, 10.1038/sj.onc.1203699 Lee, 2001, Protective role of Bcl-2 in metabolic oxidative stress-induced cell death, J Cell Sci, 114, 677, 10.1242/jcs.114.4.677 Sawada, 2001, p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells, Oncogene, 20, 1368, 10.1038/sj.onc.1204207 Deigner, 2001, Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis, FASEB J, 15, 807, 10.1096/fj.15.3.807 Paris, 2001, Endothelial Apoptosis as the primary lesion initiating intestinal radiation damage in mice, Science, 293, 293, 10.1126/science.1060191 Ségui, 2000, Stress-induced apoptosis is not mediated by endolysosomal ceramide, FASEB J, 14, 36, 10.1096/fasebj.14.1.36 Radin, 2001, Killing cancer cells by poly-drug elevation of ceramide levels: A hypothesis whose time has come, Eur J Biochem, 268, 193, 10.1046/j.1432-1033.2001.01845.x Pahan, 1999, Induction of the manganese superoxide dismutase gene by sphingomyelinase and ceramide, J Neurochem, 73, 513, 10.1046/j.1471-4159.1999.0730513.x Bose, 2000, Measurement of ceramide synthase activity, Methods Enzymol, 322, 378, 10.1016/S0076-6879(00)22035-1 Perry, 2000, serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis, J Biol Chem, 275, 9078, 10.1074/jbc.275.12.9078 Wieder, 1998, Induction of ceramide- mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine, J Biol Chem, 273, 11025, 10.1074/jbc.273.18.11025 Kroesen, 2001, Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria, J Biol Chem, 276, 13606, 10.1074/jbc.M009517200 Wang, 2001, N-(4-Hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase, Cancer Res, 61, 5102 Senchenkov, 2001, Targeting ceramide metabolism-a strategy for overcoming drug resistance, J Natl Cancer Inst, 93, 347, 10.1093/jnci/93.5.347 Sietsma, 2001, The involvement of sphingolipids in multidrug resistance, J Membrane Biol, 181, 153, 10.1007/s00232-001-0033-1 Wang, 1999, Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy, Cancer Res, 29, 5842 Myrick, 1999, Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide, Leuk Res, 23, 569, 10.1016/S0145-2126(99)00048-X Modrak, 2000, Sphingomyelin potentiates chemotherapy of human cancer xenographs, Biochem Biophys Res Commun, 268, 603, 10.1006/bbrc.2000.2178 Liu, 2001, Ceramide glycosylation potentiates cellular multidrug resistance, FASEB J, 15, 719, 10.1096/fj.00-0223com Lucci, 1998, Glucosylceramide: a marker for multiple-drug resistant cancers, Anticancer Res., 18, 475 Morjani, 2001, Elevation of glucosylceramide in multidrug-resistant cancer cells and acculumation in cytoplasmic droplets, Int J Cancer, 94, 157, 10.1002/ijc.1449 Marks, 2001, Identification of active site residues in glucosylceramide synthase, J Biol Chem, 276, 26492, 10.1074/jbc.M102612200 Tepper, 2000, Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens, J Biol Chem, 275, 34810, 10.1074/jbc.M005142200 Goulding, 2000, SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein, Cancer Lett, 149, 143, 10.1016/S0304-3835(99)00353-5 Kok, 2000, Differential expression of sphingolipids in MRP1 overexpressing HT29 cells, Int J Cancer, 87, 172, 10.1002/1097-0215(20000715)87:2<172::AID-IJC3>3.0.CO;2-K Frijters, 1999, The role of different P-glycoproteins in hepatobiliary secretion of fluorescently labeled short-chain phospholipids, J Lipid Res, 40, 1950, 10.1016/S0022-2275(20)32418-4 Raggers, 1999, The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane, J Cell Sci, 112, 415, 10.1242/jcs.112.3.415 Lala, 2000, Retroviral transfection of Madin-Darby Canine Kidney Cells with human MDR1 results in a major increase in Globotriaosylceramide and 105- to 106-fold increased cell sensitivity to Verocytotoxin, J Biol Chem, 275, 6246, 10.1074/jbc.275.9.6246 Pallis, 2000, P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway, Blood, 95, 2897, 10.1182/blood.V95.9.2897.009k14_2897_2904 Côme, 1999, Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: Influence of drug transport abnormalities, Int J Cancer, 81, 580, 10.1002/(SICI)1097-0215(19990517)81:4<580::AID-IJC13>3.0.CO;2-T Lavie, 2001, Upregulation of caveolin in multidrug resistant cancer cells: functional implications, Adv Drug Deliv Rev, 49, 317, 10.1016/S0169-409X(01)00144-2 Olshefski, 2001, Glucosylceramide synthase inhibition exhances vincristine-induced cytotoxicity, Int J Cancer, 93, 131, 10.1002/ijc.1301 Maurer, 2000, Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism, J Natl Cancer Inst, 92, 1897, 10.1093/jnci/92.23.1897 Mehta, 2000, Combined cytotxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line, Cancer Chemother Pharmacol, 46, 85, 10.1007/s002800000140 Modrak, 2000, Sphingomyelin potentiates chemotherapy of human cancer xenografts, Biochem Biophys Res Commun, 268, 603, 10.1006/bbrc.2000.2178 Schmelz, 2001, Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids, Cancer Res, 61, 6723